Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Abstract Background The creation of breast cancer practice guidelines requires proper management of financial relationships with drug companies, as they can introduce conflicts of interest (COIs) among guideline authors. However, little is known about the specific landscape and fraction of financial...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Anju Murayama, Kenichi Higuchi, Keerthana R. Byreddy, Kugo Hinari, Yuki Senoo
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2024-06-01
Cyfres:	Clinical and Translational Discovery
Pynciau:	clinical practice guideline conflicts of interest ethics evidence‐based medicine health policy pharmaceutical companies
Mynediad Ar-lein:	https://doi.org/10.1002/ctd2.304
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!